hotspot -WSS

hotspot

author：leisure time 2025-10-02 06:33:48 - browse：36678

Miniature people figurines standing in a group looking down. -- health tech coverage from STAT — Adobe

In less than two years, digital health’s high-flying class of public debuts have landed with a resounding thud.

Accelerated by the pandemic’s forced adoption of telehealth and other digital health solutions, 2021 saw more than 30 health technology startups go public, raising hundreds of millions and in some cases billions of dollars. Today, three members of the class of 2021 have gone bankrupt. Twelve companies have lost more than 90% of their initial value, including Bright Health Group, Cue Health, and Better Therapeutics. And dangerously low reserves have inspired desperate moves to slash costs, drum up liquidity, and find buyers.

Most recently, the bankruptcy of digital primary care company Babylon Health has drawn attention to the plight of newly-public health tech companies, and how the froth of dealmaking at the height of the pandemic led to overblown valuations. Before its debut in June 2021, Babylon was valued at $4.2 billion; after filing for bankruptcy in August, its U.K. telemedicine business was sold for just over $600,000.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Removing probiotics from the NICU could threaten preemies' health

WSS

Removing probiotics from the NICU could threaten preemies' health

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

White House calls on federal agencies to crack down on AI abuses

Senate panel clears PBM, hopsital reforms

Medicare will require more price transparency from hospitals

To bolster infectious disease surveillance, genomics powerhouses team up

explore

hotspot

entertainment

Apple is now the first public company to be valued at $3 trillion

Flu vaccine reformulation won't be easy, manufacturers warn

Psychedelics group wrestles with new pharma identity

The inclusion problem at the heart of rehabilitation research

New air purifier tech could be key to improving indoor air quality

Ambulance rides for just $100? Advisers want major billing fixes

How to save PrEP access — and even expand it

Prior authorization reform is both possible and imperative

How one medical school became remarkably diverse

Diversify hospital leadership teams to protect BIPOC patient health

hotspot

Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

A clever new way to fix Medicaid and graduate medical education

FDA sets aggressive timeline for overhauling inspection procedures

Medicare drug price lawsuits could be good politics for Biden

Ambulance rides for just $100? Advisers want major billing fixes

Sanofi CEO defends move to abandon profit guidance, boost research

leisure time

explore

explore

hotspot